BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26919254)

  • 1. Methylation of DACT2 accelerates esophageal cancer development by activating Wnt signaling.
    Zhang M; Linghu E; Zhan Q; He T; Cao B; Brock MV; Herman JG; Xiang R; Guo M
    Oncotarget; 2016 Apr; 7(14):17957-69. PubMed ID: 26919254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing NKD2 by Promoter Region Hypermethylation Promotes Esophageal Cancer Progression by Activating Wnt Signaling.
    Cao B; Yang W; Jin Y; Zhang M; He T; Zhan Q; Herman JG; Zhong G; Guo M
    J Thorac Oncol; 2016 Nov; 11(11):1912-1926. PubMed ID: 27374455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of DACT2 promotes breast cancer development by activating Wnt signaling.
    Li J; Zhang M; He T; Li H; Cao T; Zheng L; Guo M
    Sci Rep; 2017 Jun; 7(1):3325. PubMed ID: 28607412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation of DACT2 promotes papillary thyroid cancer metastasis by activating Wnt signaling.
    Zhao Z; Herman JG; Brock MV; Sheng J; Zhang M; Liu B; Guo M
    PLoS One; 2014; 9(11):e112336. PubMed ID: 25375359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic regulation of the Wnt signaling inhibitor DACT2 in human hepatocellular carcinoma.
    Zhang X; Yang Y; Liu X; Herman JG; Brock MV; Licchesi JD; Yue W; Pei X; Guo M
    Epigenetics; 2013 Apr; 8(4):373-82. PubMed ID: 23449122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic silencing of JAM3 promotes esophageal cancer development by activating Wnt signaling.
    Yang W; Guo C; Herman JG; Zhu C; Lv H; Su X; Zhang L; Zhang M; Guo M
    Clin Epigenetics; 2022 Dec; 14(1):164. PubMed ID: 36461092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic regulation of DACT2, a key component of the Wnt signalling pathway in human lung cancer.
    Jia Y; Yang Y; Brock MV; Zhan Q; Herman JG; Guo M
    J Pathol; 2013 Jun; 230(2):194-204. PubMed ID: 22806826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of hypermethylation in promoter region of ubiquitin carboxyl-terminal hydrolase L1 in human esophageal cancer].
    Yan WJ; Guo MZ; Yang YS
    Zhonghua Nei Ke Za Zhi; 2012 May; 51(5):390-3. PubMed ID: 22883340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XAF1 is frequently methylated in human esophageal cancer.
    Chen XY; He QY; Guo MZ
    World J Gastroenterol; 2012 Jun; 18(22):2844-9. PubMed ID: 22719195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
    Guo YL; Shan BE; Guo W; Dong ZM; Zhou Z; Shen SP; Guo X; Liang J; Kuang G
    J Biomed Sci; 2017 Jan; 24(1):6. PubMed ID: 28077137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest.
    Zhang Y; Fan J; Fan Y; Li L; He X; Xiang Q; Mu J; Zhou D; Sun X; Yang Y; Ren G; Tao Q; Xiang T
    Clin Epigenetics; 2018 Feb; 10(1):26. PubMed ID: 30359298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DACT2 is a functional tumor suppressor through inhibiting Wnt/β-catenin pathway and associated with poor survival in colon cancer.
    Wang S; Dong Y; Zhang Y; Wang X; Xu L; Yang S; Li X; Dong H; Xu L; Su L; Ng SS; Chang Z; Sung JJ; Zhang X; Yu J
    Oncogene; 2015 May; 34(20):2575-85. PubMed ID: 25023701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic silencing of IGFBPL1 promotes esophageal cancer growth by activating PI3K-AKT signaling.
    Liu Y; Zhang M; He T; Yang W; Wang L; Zhang L; Guo M
    Clin Epigenetics; 2020 Feb; 12(1):22. PubMed ID: 32041673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of the methylation of Wnt pathway antagonists-CXXC4, DACT2, and the inhibitors of sonic hedgehog signaling-ZIC1, ZIC4, and HHIP in head and neck squamous cell carcinomas.
    Paluszczak J; Wiśniewska D; Kostrzewska-Poczekaj M; Kiwerska K; Grénman R; Mielcarek-Kuchta D; Jarmuż-Szymczak M
    Clin Oral Investig; 2017 Jun; 21(5):1777-1788. PubMed ID: 27553089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DACT2 is frequently methylated in human gastric cancer and methylation of DACT2 activated Wnt signaling.
    Yu Y; Yan W; Liu X; Jia Y; Cao B; Yu Y; Lv Y; Brock MV; Herman JG; Licchesi J; Yang Y; Guo M
    Am J Cancer Res; 2014; 4(6):710-24. PubMed ID: 25520862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic silencing of RASSF10 promotes tumor growth in esophageal squamous cell carcinoma.
    Lu D; Ma J; Zhan Q; Li Y; Qin J; Guo M
    Discov Med; 2014 Apr; 17(94):169-78. PubMed ID: 24759621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic silencing of TMEM176A promotes esophageal squamous cell cancer development.
    Wang Y; Zhang Y; Herman JG; Linghu E; Guo M
    Oncotarget; 2017 Sep; 8(41):70035-70048. PubMed ID: 29050260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DACT2 silencing by promoter CpG methylation disrupts its regulation of epithelial-to-mesenchymal transition and cytoskeleton reorganization in breast cancer cells.
    Xiang T; Fan Y; Li C; Li L; Ying Y; Mu J; Peng W; Feng Y; Oberst M; Kelly K; Ren G; Tao Q
    Oncotarget; 2016 Oct; 7(43):70924-70935. PubMed ID: 27708215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation of ZNF331 Promotes Cell Invasion and Migration in Human Esophageal Cancer.
    Jiang S; Linghu E; Zhan Q; Han W; Guo M
    Curr Protein Pept Sci; 2015; 16(4):322-8. PubMed ID: 25929867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of SOX17 by microRNA 141 and methylation activates the WNT signaling pathway in esophageal cancer.
    Jia Y; Yang Y; Zhan Q; Brock MV; Zheng X; Yu Y; Herman JG; Guo M
    J Mol Diagn; 2012 Nov; 14(6):577-85. PubMed ID: 22921431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.